Skip to main content

. 1989 Apr;52(4):544. doi: 10.1136/jnnp.52.4.544

Subcutaneous apomorphine in Parkinson's disease.

P Pollak, A S Champay, M Hommel, J E Perret, A L Benabid

PMCID: PMC1032319 PMID: 2738604

544

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Agid Y., Pollak P., Bonnet A. M., Signoret J. L., Lhermitte F. Bromocriptine associated with a peripheral dopamine blocking agent in treatment of Parkinson's disease. Lancet. 1979 Mar 17;1(8116):570–572. doi: 10.1016/s0140-6736(79)91003-1. [DOI] [PubMed] [Google Scholar]
Cotzias G. C., Papavasiliou P. S., Tolosa E. S., Mendez J. S., Bell-Midura M. Treatment of Parkinson's disease with aporphines. Possible role of growth hormone. N Engl J Med. 1976 Mar 11;294(11):567–572. doi: 10.1056/NEJM197603112941101. [DOI] [PubMed] [Google Scholar]
Obeso J. A., Grandas F., Vaamonde J., Rosario Luguin M., Martínez-Lage J. M. Apomorphine infusion for motor fluctuations in Parkinson's disease. Lancet. 1987 Jun 13;1(8546):1376–1377. doi: 10.1016/s0140-6736(87)90679-9. [DOI] [PubMed] [Google Scholar]
Stibe C. M., Lees A. J., Kempster P. A., Stern G. M. Subcutaneous apomorphine in parkinsonian on-off oscillations. Lancet. 1988 Feb 20;1(8582):403–406. doi: 10.1016/s0140-6736(88)91193-2. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES